EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical and Genetic Characterization of Esophageal Atresia: A Contemporary Cohort Integrating Phenotyping and Genomic Testing

Purificacion Marin-Reina iD, Irene Reig Talamante, Anna Parra Llorca, Inmaculada Navarro Escandell, Carla Martin Grau iD, Angel Zuñiga Cabrera, Cinta Navarro Moreno iD, Alba Gabaldon Albero iD, Carmen Orellana Alonso iD, Monica Rosello Piera iD, Pilar Saenz Gonzalez iD, Francisco Martinez Castellano iD

Genes · 01.06.2026 · 17 (6) · 654

DOI: 10.3390/genes17060654 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, online erschienen am 01.06.2026. Verfasst von Purificacion Marin-Reina und 11 weiteren Autor:innen. Beteiligte Einrichtung: Dysmorphology and Pediatric Rare Diseases, Division of Neonatology, Hospital Universitari i Politècnic La Fe (HULAFE), 46026 Valencia, Spain. Hauptthemen laut MEDLINE: Esophageal Atresia, Genetic Testing. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Esophageal atresia (EA) is a complex congenital anomaly frequently associated with additional malformations and genetic conditions. Despite advances in prenatal imaging and genomic technologies, establishing an etiologic diagnosis and performing accurate risk stratification remain challenging due to marked clinical and genetic heterogeneity.

Methods

We conducted a retrospective cohort study of neonates diagnosed with EA and admitted to a level IIIc neonatal intensive care unit between 2005 and 2024. Prenatal findings, associated anomalies, genetic testing results, mortality, and neurodevelopmental outcomes beyond 12 months were analyzed.

Results

A total of 105 neonates were included, of whom 10.5% were diagnosed prenatally. Isolated EA was identified in 55.2% of patients, whereas 44.8% had associated anomalies, most commonly congenital cardiac defects. Clinically relevant genetic findings were identified in 10.5% of the total cohort (23.4% of complex EA cases). These findings reflect a clinically selected subgroup and should not be interpreted as diagnostic yields applicable to unselected populations or as a comparison between testing modalities. Overall mortality was 11.4%. Lower birth weight showed the strongest association with mortality in univariable analyses; however, no independent predictors were inferred due to the limited number of events. All deceased patients had complex malformative conditions and/or extreme prematurity. Among children with follow-up beyond 12 months, 88.5% demonstrated age-appropriate neurodevelopment.

Conclusions

EA is characterized by substantial etiologic and phenotypic heterogeneity. Prenatal detection remains challenging, although advances in fetal imaging may improve diagnostic accuracy. A phenotype-guided approach integrating clinical evaluation and genetic testing may support etiologic diagnosis, recurrence counseling, and follow-up planning in selected patients. However, because testing was indication-driven and evolved over time, the reported diagnostic yields should not be generalized to unselected EA populations or interpreted as comparative performance across testing modalities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal AtresiaGenetic TestingHumansFemalePhenotypeInfant, NewbornRetrospective StudiesMalePrenatal DiagnosisPregnancy

Stichwörter der Autor:innen

VACTERL associationesophageal atresiagenetic testingmortalityneurodevelopmentphenotype-guided approachprenatal diagnosistracheoesophageal fistula

Autor:innen und Institutionen

  • Dysmorphology and Pediatric Rare Diseases, Division of Neonatology, Hospital Universitari i Politècnic La Fe (HULAFE), 46026 Valencia, Spain.
  • Neonatal Research Group, Instituto de Investigación Sanitaria La Fe (IISLAFE), 46026 Valencia, Spain.
  • Division of Neonatology, Hospital Universitari i Politècnic La Fe (HULAFE), 46026 Valencia, Spain.
  • Facultad de Medicina, Universitat de València, 46010 Valencia, Spain.
  • Genetics Unit, Hospital Universitari i Politècnic La Fe (HULAFE), 46026 Valencia, Spain.
  • Translational Genetics Research Group, Instituto de Investigación Sanitaria La Fe (IIS La Fe), 46026 Valencia, Spain.

ORCID-Profile: Purificacion Marin-Reina, Carla Martin Grau, Cinta Navarro Moreno, Alba Gabaldon Albero, Carmen Orellana Alonso, Monica Rosello Piera, Pilar Saenz Gonzalez, Francisco Martinez Castellano

Zitieren

APA

Marin-Reina, P., Reig Talamante, I., Parra Llorca, A., Navarro Escandell, I., Martin Grau, C., Cabrera, A. Z., Navarro Moreno, C., Gabaldon Albero, A., Orellana Alonso, C., Rosello Piera, M., Saenz Gonzalez, P., & Martinez Castellano, F. (2026). Clinical and Genetic Characterization of Esophageal Atresia: A Contemporary Cohort Integrating Phenotyping and Genomic Testing. Genes, 17(6), 654. https://doi.org/10.3390/genes17060654

Vancouver

Marin-Reina P, Reig Talamante I, Parra Llorca A, Navarro Escandell I, Martin Grau C, Cabrera AZ, et al. Clinical and Genetic Characterization of Esophageal Atresia: A Contemporary Cohort Integrating Phenotyping and Genomic Testing. Genes. 2026;17(6):654. doi:10.3390/genes17060654

BibTeX
@article{MarinReina2026,
  author = {Marin-Reina, Purificacion and Reig Talamante, Irene and Parra Llorca, Anna and Navarro Escandell, Inmaculada and Martin Grau, Carla and Cabrera, Angel Zuñiga and Navarro Moreno, Cinta and Gabaldon Albero, Alba and Orellana Alonso, Carmen and Rosello Piera, Monica and Saenz Gonzalez, Pilar and Martinez Castellano, Francisco},
  title = {Clinical and Genetic Characterization of Esophageal Atresia: A Contemporary Cohort Integrating Phenotyping and Genomic Testing},
  journal = {Genes},
  year = {2026},
  volume = {17},
  number = {6},
  pages = {654},
  doi = {10.3390/genes17060654}
}
Kostenlos starten →